Vicki Pearson, global solutions architect, life sciences at Schneider Electric, provides an Expert View on how firms can meet a growing demand while remaining a 30 November 2021
As the initial waves of the coronavirus pandemic hit in early 2020, pharma and biotech stocks saw major declines as investors digested the likely impact. 11 November 2021
New European Union (EU) regulation requires life sciences companies’ data in the clinical trial master file (TMF) to remain secure, accessible, and usable for a 15 October 2021
Research undertaken at the University of Bristol, UK, paves the way for a novel artificial intelligence (AI)-driven platform for growing and treating virtual tu 22 September 2021
For many years, artificial intelligence (AI), in particular machine learning, have been touted as potentially transformational technologies for drug discovery a 16 August 2021
Raman Sehgal, the founder of ramarketing, provides an Expert View on how pharmaceutical and life sciences businesses can market themselves in the post-pandemic 10 August 2021
As across the world, the migraine therapeutics landscape in Japan is growing with the recent approval of calcitonin gene-related peptide (CGRP) inhibitors as pr 8 July 2021
A new R&D collaboration between Japanese drugmaker Sosei Group and USA-based InveniAI will see the firms working together on new “therapeutic product concepts” 6 July 2021
AJ Ploszay, VP of digital strategy, IQVIA, provides an Expert View on how the precedent for consumer buying set by companies like Amazon, further accelerated by 20 May 2021
Hannah Schofield, associate at Hogan Lovells, considers the option of utilizing blockchain technology for accurate tracking and monitoring in an Expert View pie 7 April 2021
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.